Publications
June 7, 2017

Maine WC Appellate Division Places Burden on Employee to Prove Unavailability of Generic Prescription Drugs

Maine Workers' Comp Alert

In Belanger v. Miles Memorial Hospital, Me. WCB App. Div. No. 17-23 (May 25, 2017), Miles Memorial Hospital appealed from a decision of an ALJ granting, among other things, an employee’s Petition for Payment of Medical and Related Expenses, in part. The employer argued that the ALJ erred in failing to apply 39-A M.R.S.A. § 206(11) to deny payment for brand-named drugs. The Appellate Division vacated and modified in part the decision to the extent it required payment for brand-named drugs.

Section 206(11) (“Generic Drugs”) states, “[p]roviders shall prescribe generic drugs whenever medically acceptable for the treatment of an injury or disease for which compensation is claimed. An employee shall purchase generic drugs for the treatment of an injury or disease for which compensation is claimed if the prescribing provider indicates that generic drugs may be used and if generic drugs are available at the time and place of purchase under subsection 11-A. . . .”

The employer argued that because generic drugs were available on some occasions they must have been available at the time and place the employee was given the brand name medication. The employer alternatively argued that the burden of proof on the issue of whether generic drugs were available rests with the employee, and thus, the lack of evidence on this issue should have resulted in a denial of the employee’s claim for reimbursement of the cost of brand name drugs.

The Appellate Division read § 206(11) to place an affirmative obligation on providers to prescribe generic drugs and on employees to use the generic version if two conditions are met: (1) the provider has indicated that the generic version is appropriate; and (2) the generic version is available at the time and place of purchase. Except in unusual circumstances, the party filing a claim bears the burden of proof on all elements of that claim. The Appellate Division found “no reason to alter that burden in this circumstance.” Further, “[i]t is the employee who is present at the time and place of purchase of any medication. Placing the obligation on the employee to show unavailability of the the generic version of a drug is consistent with the affirmative burden placed upon employees by section 206(11), and is not an onerous burden.”

Firm Highlights

Publication

Maine Workers' Comp Alert: WCB Announces New Nature and Cause of Injury Codes and FAQ for COVID-19

New Nature & Cause of Injury Codes The Maine Workers’ Compensation Board (WCB) has updated the Injury Description Tables that are used by the International Association of Industrial Accident Boards and Commissions (IAIABC) to...

Publication

Maine Workers' Comp Alert: WCB Announces Updates to Several Forms

The Maine Workers’ Compensation Board has revised several forms, which are now available here . The WCB-4 (Discontinuance/Modification) has been divided into two new forms, WCB-4D (Discontinuance) and WCB-4M (Modification). The Discontinuance, Modification, and...

News

48 Preti Flaherty Attorneys Selected by Peers for Inclusion in Best Lawyers in America 2021, Including 4 “Lawyers of the Year”

Forty-eight Preti Flaherty attorneys have been named to Best Lawyers in America 2021, including four recognized on the inaugural “Ones to Watch” list for attorneys earlier in their careers and four “Lawyer of the...

Publication

Maine Workers' Comp Alert: WCB Transition to In-Person Hearings Likely to Occur No Sooner Than August 2020; Section 312 IME’s Have Resumed

A conference with Maine Workers' Compensation Board Executive Director John Rohde was held last week to discuss the transition to in-person hearings at the WCB. The WCB Subcommittees also met to discuss recent developments...

Publication

Maine WC Alert: WCB Orders Remote Hearings Unless In-Person Deemed Necessary

COVID-19 Concerns Prompt Maine WCB to Order That Hearings Be Conducted Remotely Unless It Is Deemed Necessary to Conduct a Hearing In-Person On March 25, 2020, the Maine WCB issued an order regarding the...

Publication

Maine Workers' Comp Alert: Areas of Consideration Due to COVID-19

This alert addresses certain areas of concern with respect to the COVID-19 pandemic and Maine Workers’ Compensation. This alert touches upon new issues to consider, issues of concern for existing claims, and general concerns...

Publication

Maine Workers' Comp Alert: Update on Appellate Division Findings on Notice of Injury Requirements

Maine WC Appellate Division Affirms Decision Finding Untimely Notice of Injury; Reiterates Requirements for Timely Notice As background, the notice period is 90 days for dates of injury between January 1, 1993, and January...

Publication

Update on COVID-19 and Maine Workers' Compensation

In this uncertain time, Preti Flaherty wants to assure you we are still providing full coverage for your Maine Workers’ Compensation and Longshore legal needs. This update briefly addresses current laws and also touches...

Publication

WC Alert: Recent Developments from Maine's Workers' Compensation Board

Frank A. Graf, MD, Reappointed to Approved List of § 312 Examiners At the February 11 meeting of the Maine Workers’ Compensation Board, Frank Graf, MD, was reappointed to the list of approved § 312...

News

Attorney Evan Hansen Selected by Peers as “Lawyer of the Year” in Best Lawyers in America 2021

Preti Flaherty attorney Evan Hansen has been recognized in Best Lawyers in America 2021 as the “Lawyer of the Year” for the Portland region in the field of Workers' Compensation Law - Employers. Inclusion in...